Chargement en cours...
Safety and Efficacy of Fremanezumab for the Prevention of Migraine: A Meta-Analysis From Randomized Controlled Trials
Background: Fremanezumab (TEV-48125) is a fully-humanized immunoglobulin G isotype 2a selective monoclonal antibody that potently binds to calcitonin gene-related peptide (CGRP). It is one of the novel therapeutic drugs for the prevention of migraine, which is one of the most common neurological dis...
Enregistré dans:
| Publié dans: | Front Neurol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7248404/ https://ncbi.nlm.nih.gov/pubmed/32508742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00435 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|